The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis
The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis
复制标题
DOI:
10.1186/s41927-019-0092-5
复制
发表时间:
2019-01-01
期刊:
影响因子:
2.2
通讯作者:
Li, Nan
中科院分区:
文献类型:
--
作者:
Peterson, Steve;Piercy, James;Li, Nan
Background: The prevalence of mood disturbances such as anxiety and depression is greater in rheumatoid arthritis (RA) patients than in the general population. Given this association, the primary aim of this study was to assess the incremental impact of anxiety or depression on patients with RA from the United States of America (USA) and Europe, independent of the impact of the underlying RA disease. Methods: Rheumatologists (n=408) from the USA and 5 European countries completed patient record forms for a predetermined number of RA patients who consulted consecutively during the study period; these patients completed patient-reported questionnaires. Descriptive statistics and multivariate regression were used to investigate the relationship between anxiety and depression with treatment and economic outcomes in RA patients. Results: Of 1015 physician and patient pairs who completed all relevant questionnaire sections, 390 (38.4%) patients self-reported anxiety or depression, while 180 (17.7%) patients were reported to have anxiety or depression by their physicians. Controlling for age, gender, body mass index and clinical factors (flaring and severity), multiple regression analyses suggested that patients with anxiety or depression more often experienced treatment dissatisfaction (odds ratio [OR] 2.28; P